SNCA and melanoma: For example, one study found that TIGIT and PD-1 co-expressed on most NY-ESO-1-specific CD8+ T cells isolated from melanoma patients, and dual blockades of TIGIT and PD-1 further increased NY-ESO-1-specific CD8+ T cell counts.